Synonyms for eclampsia or Related words with eclampsia

preeclampsia              hypercoagulability              thrombopenia              iugr              hellp              peripartum              toxemia              hyperbilirubinemia              miscarriage              ohss              hyperuricemia              microalbuminuria              hypercortisolism              diathesis              gravidarum              hemoglobinopathy              embryopathy              hypovolemia              kernicterus              hypocalcemia              prediabetes              leukocytopenia              coagulopathies              pcos              hyperandrogenic              endometriosis              polyhydramnios              hyperphosphatemia              thrombophilic              hyperinsulinism              menorrhagia              metrorrhagia              polymenorrhea              hyperemesis              malady              hemoglobinemia              coagulopathy              hyperthyroidism              microangiopathic              dysfibrinogenemia              puerperium              antepartum              bilirubinemia              pregnancy              hyperhomocystinemia              appendicitis              hypogonadism              azoospermia              urosepsis              hypomagnesemia             

Examples of "eclampsia"
Pre-eclampsia and eclampsia are sometimes treated as components of a common syndrome.
Eclampsia, like pre-eclampsia, tends to occur more commonly in first pregnancies and young mothers where it is thought that novel exposure to paternal antigens is involved. Furthermore, women with pre-existing vascular diseases (hypertension, diabetes, and nephropathy) or thrombophilic diseases such as the antiphospholipid syndrome are at higher risk to develop pre-eclampsia and eclampsia. Having a large placenta (multiple gestation, hydatidiform mole) also predisposes women to eclampsia. In addition, there is a genetic component: a woman whose mother or sister had the condition is at higher risk than otherwise. Women who have experienced eclampsia are at increased risk for pre-eclampsia/eclampsia in a later pregnancy. Pulmonary edema is a rather common complication of severe eclampsia affecting approximately 3% of the people with eclampsia: most is caused by too much intravenous fluid.
The intrapartum and postpartum administration of magnesium sulfate is recommended in severe pre-eclampsia for the prevention of eclampsia. Further, magnesium sulfate is recommended for the treatment of eclampsia over other anticonvulsants. Magnesium sulfate acts by interacting with NMDA receptors.
Eclampsia is a major complication of pre-eclampsia. Eclampsia affects 0.56 per 1000 pregnant women in developed countries and almost 10–30 times as many women in low-income countries as in developed countries.
Detection and management of pre-eclampsia is critical to reduce the risk of eclampsia. Appropriate management of women with pre-eclampsia generally involves the use of magnesium sulphate to prevent convulsions.
Convulsions during pregnancy that are unrelated to pre-eclampsia need to be distinguished from eclampsia. Such disorders include seizure disorders as well as brain tumor, aneurysm of the brain, and medication- or drug-related seizures. Usually the presence of the signs of severe pre-eclampsia precede and accompany eclampsia, facilitating the diagnosis.
Pre-eclampsia is a progressive disorder and these signs of organ dysfunction are indicative of severe pre-eclampsia. A systolic blood pressure ≥160 or diastolic blood pressure ≥110 and/or proteinuria >5g in a 24-hour period is also indicative of severe pre-eclampsia. Clinically, individuals with severe pre-eclampsia may also present epigastric/right upper quadrant abdominal pain, headaches, and vomiting. Severe pre-eclampsia is a significant risk factor for intrauterine fetal death.
There is no specific treatment, but is monitored closely to rapidly identify pre-eclampsia and its life-threatening complications (HELLP syndrome and eclampsia).
Of note is that pregnancy associated affections like pre-eclampsia, eclampsia and HELLP syndrome can overlap in their presentation as pregnancy can trigger TTP episodes.
Suspicion for pre-eclampsia should be maintained in any pregnancy complicated by elevated blood pressure, even in the absence of proteinuria. Ten percent of individuals with other signs and symptoms of pre-eclampsia and 20% of individuals diagnosed with eclampsia show no evidence of proteinuria. In the absence of proteinuria, the presence of new-onset hypertension (elevated blood pressure) and the new onset of one or more of the following is suggestive of the diagnosis of pre-eclampsia:
Pre-eclampsia affects 2–8% of pregnancies worldwide. Hypertensive disorders of pregnancy (which include pre-eclampsia) are one of the most common causes of death due to pregnancy. They resulted in 29,000 deaths in 2013 – down from 37,000 deaths in 1990. Pre-eclampsia usually occurs after 32 weeks; however, if it occurs earlier it is associated with worse outcomes. Women who have had pre-eclampsia are at increased risk of heart disease and stroke later in life. The word eclampsia is from the Greek term for lightning. The first known description of the condition was by Hippocrates in the 5th century BC.
González, Agustín Mateo - Eclampsia puerperal - 1916, Página 84
Pre-eclampsia is diagnosed when a pregnant woman develops:
VEGF alterations can be predictive of early-onset pre-eclampsia.
Complications of pre-eclampsia can affect both the mother and the fetus. Acutely, pre-eclampsia can be complicated by eclampsia, the development of HELLP syndrome, hemorrhagic or ischemic stroke, liver damage and dysfunction, acute kidney injury, and acute respiratory distress syndrome (ARDS).
Zone 1 (periportal) occurs in phosphorus poisoning or eclampsia.
Preventative measures against pre-eclampsia have been heavily studied. Because the pathogenesis of pre-eclampsia is not completely understood, prevention remains a complex issue. Below are some of the currently accepted recommendations.
Pre-eclampsia affects approximately 2–8% of all pregnancies worldwide, The incidence of pre-eclampsia has risen in the USA since the 1990s, possibly as a result of increased prevalence of predisposing disorders, such as chronic hypertension, diabetes, and obesity.
Magnesium taurate has been suggested with applicability to vascular protection, myocardial infarction, pre-eclampsia, eclampsia, perinatal asphyxia, and migraine. It has been studied in rats for delaying the onset and progression of cataract.
Supplementation with antioxidants such as vitamin C, D and E has no effect on pre-eclampsia incidence; therefore, supplementation with vitamins C, E, and D is not recommended for reducing the risk of pre-eclampsia.